Does Rallies show Form 4 insider transactions for GENB?

Yes. Rallies tracks GENB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GENB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GENB. It does not provide personalized investment advice.

GENB (Generate Biomedicines, Inc. Common Stock) Stock Analysis - Insider Trades

Generate Biomedicines, Inc. Common Stock (GENB) is a publicly traded the market company. As of May 21, 2026, GENB trades at $13.25 with a market cap of $1.67B and a P/E ratio of -12.06. GENB moved +5.07% today. Year to date, GENB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $11.00 to $16.75. Analyst consensus is strong buy with an average price target of $25.40. Rallies surfaces GENB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GENB stock inside the company?

Recent GENB insider activity includes Nally Michael bought 20.00K, Grous Beth bought 300, Silvers Jason bought 500, Silvers Jason bought 500, and Silvers Jason bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GENB Key Metrics

Key financial metrics for GENB
Metric	Value
Price	$13.25
Market Cap	$1.67B
P/E Ratio	-12.06
EPS	$-1.07
Dividend Yield	0.00%
52-Week High	$16.75
52-Week Low	$11.00
Volume	827.46K
Avg Volume	0
Revenue (TTM)	$7.22M
Net Income	$-61.71M
Gross Margin	0.00%

Recent GENB Insider Trades

Nally Michael bought 20.00K (~$240.00K) on Mar 4, 2026.
Grous Beth bought 300 (~$4.80K) on Mar 2, 2026.
Silvers Jason bought 500 (~$8.00K) on Mar 2, 2026.
Silvers Jason bought 500 (~$8.00K) on Mar 2, 2026.
Silvers Jason bought 1.00K (~$16.00K) on Mar 2, 2026.

Latest GENB News

Generate Biomedicines Holds $516.6M Cash, Advances GB-0895 Phase 3 and GB-4362 — May 7, 2026

GENB Analyst Consensus

6 analysts cover GENB: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.40.

Common questions about GENB

Who is trading GENB stock inside the company?: Recent GENB insider activity includes Nally Michael bought 20.00K, Grous Beth bought 300, Silvers Jason bought 500, Silvers Jason bought 500, and Silvers Jason bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GENB?: Yes. Rallies tracks GENB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GENB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GENB. It does not provide personalized investment advice.